Last updated on April 2018

Efficacy and Safety of Dexlansoprazole on Heartburn Relief in Chinese Patients


Brief description of study

The purpose of this study is to determine the efficacy of dexlansoprazole compared to placebo in relief of daytime and nighttime heartburn over 4 weeks in Chinese participants with symptomatic non-erosive Gastroesophageal Reflux Disease (GERD).

Detailed Study Description

The drug being tested in this study is called dexlansoprazole. Dexlansoprazole is being tested to treat heartburn in people who have non-erosive gastroesophageal reflux disease (GERD). This study will look at heartburn relief in people who take dexlansoprazole.

The study will enroll approximately 200 participants. Participants will be randomly assigned to one of the two treatment groups with 1:1 ratio which will remain undisclosed to the participant and study doctor during the study (unless there is an urgent medical need):

  • Dexlansoprazole 30 mg
  • Placebo (dummy inactive pill) - this is a capsule that looks like the study drug but has no active ingredient.

All participants will be asked to take one capsule at the same time each day throughout the study, and will be asked to record any time they have heartburn symptoms in a diary.

This multi-center trial will be conducted in China. The overall time to participate in this study is up to 11 weeks. Participants will make 4 visits to the clinic, and will be contacted by telephone 5 to 10 days after the last dose of study drug for a follow-up assessment.

Clinical Study Identifier: NCT02873689

Contact Investigators or Research Sites near you

Start Over

Takeda Study Registration Call Center

Peking University First Hospital
Beijing, China

Takeda Study Registration Call Center

Peking Union Medical College Hospital
Beijing, China

Takeda Study Registration Call Center

Chongqing Three Gorges Central Hospital
Chong Qing, China

Takeda Study Registration Call Center

Zhongshan Hospital Xiamen University
Xia Men, China

Takeda Study Registration Call Center

The People's Hospital of Guangxi Zhuang Autonomous Region
Nan Ning, China

Takeda Study Registration Call Center

Affilicated Hospital of Guilin Medical University
Hai Kou, China

Takeda Study Registration Call Center

Hebei General Hospital
Shijiazhuang, China

Takeda Study Registration Call Center

Taihe Hospital
Shi Yan, China

Takeda Study Registration Call Center

Central Hospital of Wuhan
Wuhan, China

Takeda Study Registration Call Center

Puai Hospital Of Wuhan City
Wuhan, China

Takeda Study Registration Call Center

The Third Hospital of Changsha
Chang Sha, China

Takeda Study Registration Call Center

Zhongda Hospital Southeast
Nan Jing, China

Takeda Study Registration Call Center

Affiliated Hospital of Jiangsu University
Wu Xi, China

Takeda Study Registration Call Center

Wuxi people's hospital
Wu XI, China

Takeda Study Registration Call Center

The First Hospital of Jilin University
Changchun, China

Takeda Study Registration Call Center

Shengjing Hospital of China Medical University
Shenyang, China

Takeda Study Registration Call Center

Binzhou Medical University Hospital
Binzhou, China

Takeda Study Registration Call Center

Jinan Central Hospital
Jinan, China

Takeda Study Registration Call Center

Liaocheng Hospital
Liaocheng, China

Takeda Study Registration Call Center

The Affiliated Hospital of Qingdao University
Qingdao, China

Takeda Study Registration Call Center

Renji Hospital Shanghai Jiaotong University School of Medicine
Shanghai, China

Takeda Study Registration Call Center

The First Hospital of Shanxi Medical University
Taiyuan, China

Takeda Study Registration Call Center

The Second Hospital of Shanxi Medical University
Taiyuan, China

Takeda Study Registration Call Center

West China Hospital,Sichuan University
Cheng Du, China

Takeda Study Registration Call Center

Tianjin People's Hospital
Tianjin, China

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.